HighGravityDataElevance Health — Jan 28, 2026 release
Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001156039-26-000006
Showing in the filing
Dividend
“$1.72 per share”
Period
Q1 FY2026
Measure
Declared action
Source
Prose
All guidance in this release · 31
Long-term earnings algorithm and segment mar… for the long term
“Reaffirming long-term earnings algorithm; recalibrating segment margin targets”
Adjusted EPS growth for FY2027
“at least 12%”
Dividend for Q1 FY2026
“$1.72 per share”
Projected FY 2026 GAAP diluted EPS for FY2026
“at least $22.30”
Shareholders' earnings per diluted share for FY2026
“At least $22.30”
Adjusted shareholders' earnings per diluted … for FY2026
“At least $25.50”
Projected FY 2026 adjusted diluted EPS for FY2026
“at least $25.50”
Premium Revenue for FY2026
“Mid single digit decline”
Product Revenue for FY2026
“Mid single digit growth”
Service Fees for FY2026
“Mid single digit growth”
Total Operating Revenue for FY2026
“Low single digit decline”
Benefit Expense Ratio for FY2026
“90.2% +/- 50 bps”
Adjusted Operating Expense Ratio for FY2026
“10.6% +/- 50 bps”
Adjusted Operating Gain for FY2026
“At least $6.8 billion”
Net Investment income for FY2026
“$1,875 million”
Interest Expense for FY2026
“($1,530) million”
Amortization of Intangible Assets for FY2026
“($440) million”
Adjusted Effective Tax Rate for FY2026
“22.0% - 24.0%”
Diluted Shares for FY2026
“219-220 million”
Operating Cash Flow for FY2026
“At least $5.5 billion”
Operating Revenue Growth Rate: Carelon Servi… for FY2026
“Low single digit growth”
GAAP Operating Margin vs. 2025: Health Benef… for FY2026
“(50) - (25) bps”
GAAP Operating Margin vs. 2025: Carelon Serv… for FY2026
“0 - 25 bps”
Year-End Medical Enrollment: Commercial Fee-… for FY2026
“27,200 - 27,500”
Year-End Medical Enrollment: Commercial Risk… for FY2026
“4,150 - 4,250”
Year-End Medical Enrollment: Medicaid for FY2026
“7,650 - 7,850”
Year-End Medical Enrollment: Medicare Advant… for FY2026
“1,775 - 1,875”
Year-End Medical Enrollment: Medicare Supple… for FY2026
“Approximately 850”
Year-End Medical Enrollment: Federal Employe… for FY2026
“Approximately 1,550”
Year-End Medical Enrollment: Risk-Based for FY2026
“15,975 - 16,375”
Year-End Medical Enrollment: Total for FY2026
“43,175 - 43,875”
Exhibit 99.1 · the passage around this item
… earlier in the release
On a full year basis, adjusted operating gain was $3.4 billion in 2025, an increase of $0.3 billion, or 10 percent, driven by improved CarelonRx performance and growth in Carelon Services risk-based solutions. 4 Quarterly Dividend On January 27, 2026, the Audit Committee of the Company's Board of Directors declared a first quarter 2026 dividend to shareholders of $1.72 per share. The first quarter dividend is payable on March 25, 2026 to shareholders of record at the close of business on March 10, 2026. About Elevance Health Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 104 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn. Conference Call and Webcast Management will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time (“EST”) to discuss the company’s fourth quarter and full year 2025 results and 2026 outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers: 888-947-9963 (Domestic) 888-566-0046 (Domestic Replay) 312-470-0178 (International) 203-369-3677 (Internati
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.